UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 118

Sortiert nach

Molecular patterns in deficient mismatch repair colorectal tumours: results from a French prospective multicentric biological and genetic study

British journal of cancer, 2014-05, Vol.110 (11), p.2728-2737

2014

Volltextzugriff (PDF)

Thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphisms: relationships with 5-fluorouracil sensitivity

British journal of cancer, 2004-01, Vol.90 (2), p.526-534

2004

Volltextzugriff (PDF)

Epidermal growth factor receptor (EGFR) status and K-Ras mutations in colorectal cancer

Annals of oncology, 2008-12, Vol.19 (12), p.2033-2038

2008

Volltextzugriff (PDF)

Molecular mechanisms underlying the interaction between ZD1839 ('Iressa') and cisplatin 5-fluorouracil

British journal of cancer, 2003-08, Vol.89 (3), p.585-592

2003

Volltextzugriff (PDF)

EGFR in colorectal cancer: more than a simple receptor

Annals of oncology, 2006-06, Vol.17 (6), p.962-967

2006

Volltextzugriff (PDF)

Analysis of the dinucleotide repeat polymorphism in the epidermal growth factor receptor (EGFR) gene in head and neck cancer patients

Annals of oncology, 2005-06, Vol.16 (6), p.934-941

2005

Volltextzugriff (PDF)

Expression of epidermal growth factor receptor and survival in upper aerodigestive tract cancer

Journal of clinical oncology, 1993-10, Vol.11 (10), p.1873-1878

1993

Volltextzugriff (PDF)

Vascular endothelial growth factor-A and Poly(A) binding protein-interacting protein 2 expression in human head and neck carcinomas: correlation and prognostic significance

British journal of cancer, 2006-05, Vol.94 (10), p.1516-1523

2006

Volltextzugriff (PDF)

EGFR expression in colon cancer: a break in the clouds

Annals of oncology, 2006-12, Vol.17 (12), p.1850-1851

2006

Volltextzugriff (PDF)

A multifactorial approach including tumoural epidermal growth factor receptor, p53, thymidylate synthase and dihydropyrimidine dehydrogenase to predict treatment outcome in head and neck cancer patients receiving 5-fluorouracil

British Journal of Cancer, 1999-04, Vol.79 (11-12), p.1864-1869

1999

Volltextzugriff (PDF)

Epidermal growth factor receptor expression in 780 breast cancer patients: A reappraisal of the prognostic value based on an eight-year median follow-up

Annals of oncology, 2001-06, Vol.12 (6), p.841-846

2001

Volltextzugriff (PDF)

The relationship of epidermal growth factor receptor levels to the prognosis of unresectable pharyngeal cancer patients treated by chemo-radiotherapy

European journal of cancer (1990), 2001-11, Vol.37 (17), p.2169-2177

2001

Volltextzugriff (PDF)

Dihydropyrimidine dehydrogenase circadian rhythm in mouse liver: comparison between enzyme activity and gene expression

European journal of cancer (1990), 2003-04, Vol.39 (6), p.822-828

2003

Volltextzugriff (PDF)

p53 determination alongside classical prognostic factors in node-negative breast cancer: An evaluation at more than 10-year follow-up

Annals of oncology, 2000-04, Vol.11 (4), p.393-397

2000

Volltextzugriff (PDF)

Combination of irinotecan (CPT11) and 5-fluorouracil with an analysis of cellular determinants of drug activity

Biochemical pharmacology, 1998-11, Vol.56 (10), p.1315-1322

1998

Volltextzugriff (PDF)

Epidermal growth factor receptor and labeling index are independent prognostic factors in glial tumor outcome

Clinical cancer research, 1998-10, Vol.4 (10), p.2383-2390

1998

Volltextzugriff (PDF)

Application of an original RT-PCR-ELISA multiplex assay for MDR1 and MRP, along with p53 determination in node-positive breast cancer patients

British journal of cancer, 2000-01, Vol.82 (1), p.171-177

2000

Volltextzugriff (PDF)

Polymorphismes du CYP2D6 et tamoxifène : perspectives thérapeutiques dans la prise en charge des cancers du sein hormonodépendants

Bulletin du cancer, 2010-03, Vol.97 (3), p.311-320

2010

Volltextzugriff (PDF)

Decreased folylpolyglutamate synthetase activity in tumors resistant to fluorouracil-folinic acid treatment: clinical data

Clinical cancer research, 1997-04, Vol.3 (4), p.553-557

1997

Volltextzugriff (PDF)

A clinically applicable assay for tumoral thymidylate synthase combining reverse transcriptase–PCR and High-performance liquid chromatography

European journal of cancer (1990), 1998-01, Vol.34 (1), p.182-187

1998

Volltextzugriff (PDF)

Enzyme-Linked Immunosorbent Assay for Pharmacological Studies Targeting Hypoxia-Inducible Factor 1α

Clinical and Diagnostic Laboratory Immunology, 2005-05, Vol.12 (5), p.660-664

2005

Volltextzugriff (PDF)

CYP2D6 polymorphisms and tamoxifen: therapeutic perspectives in the management of hormonodependent breast cancer patients

Bulletin du cancer, 2010-03, Vol.97 (3), p.311

2010

Volltextzugriff (PDF)

Tamoxifen metabolism: pharmacokinetic and in vitro study

British journal of cancer, 1989-07, Vol.60 (1), p.30-35

1989

Volltextzugriff (PDF)

Comparison between short or long exposure to 5-fluorouracil in human gastric and colon cancer cell lines: biochemical mechanism of resistance

Anti-cancer drugs, 1998-08, Vol.9 (7), p.625-634

1998

Volltextzugriff (PDF)

Synergistic efficacy of 3n-butyrate and 5-fluorouracil in human colorectal cancer xenografts via modulation of DNA synthesis

Gastroenterology (New York, N.Y. 1943), 2001-03, Vol.120 (4), p.874-888

2001

Volltextzugriff (PDF)

1 – 25 von 118

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(109)
Mit Volltextzugriff
(102)

Publikationsform

Artikel
(118)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(87)
Life Sciences & Biomedicine
(73)
Science & Technology
(73)
Oncology
(63)
Biological And Medical Sciences
(59)
Medical Sciences
(59)
Female
(42)
Pharmacology. Drug Treatments
(39)
Antineoplastic Agents
(35)
Middle Aged
(30)
Aged
(29)
Male
(29)
Adult
(27)
Tumors
(26)
General Aspects
(20)
Aged, 80 And Over
(19)
Tumor Cells, Cultured - Drug Effects
(19)
Dose-Response Relationship, Drug
(16)
Tumor Cells, Cultured
(16)
Chemotherapy
(15)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Molecular patterns in deficient mismatch repair colorectal tumours: results from a French prospective multicentric biological and genetic study

Thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphisms: relationships with 5-fluorouracil sensitivity

Epidermal growth factor receptor (EGFR) status and K-Ras mutations in colorectal cancer

Molecular mechanisms underlying the interaction between ZD1839 ('Iressa') and cisplatin 5-fluorouracil

EGFR in colorectal cancer: more than a simple receptor

Analysis of the dinucleotide repeat polymorphism in the epidermal growth factor receptor (EGFR) gene in head and neck cancer patients

Expression of epidermal growth factor receptor and survival in upper aerodigestive tract cancer

Vascular endothelial growth factor-A and Poly(A) binding protein-interacting protein 2 expression in human head and neck carcinomas: correlation and prognostic significance

EGFR expression in colon cancer: a break in the clouds

A multifactorial approach including tumoural epidermal growth factor receptor, p53, thymidylate synthase and dihydropyrimidine dehydrogenase to predict treatment outcome in head and neck cancer patients receiving 5-fluorouracil

Epidermal growth factor receptor expression in 780 breast cancer patients: A reappraisal of the prognostic value based on an eight-year median follow-up

The relationship of epidermal growth factor receptor levels to the prognosis of unresectable pharyngeal cancer patients treated by chemo-radiotherapy

Dihydropyrimidine dehydrogenase circadian rhythm in mouse liver: comparison between enzyme activity and gene expression

p53 determination alongside classical prognostic factors in node-negative breast cancer: An evaluation at more than 10-year follow-up

Combination of irinotecan (CPT11) and 5-fluorouracil with an analysis of cellular determinants of drug activity

Epidermal growth factor receptor and labeling index are independent prognostic factors in glial tumor outcome

Application of an original RT-PCR-ELISA multiplex assay for MDR1 and MRP, along with p53 determination in node-positive breast cancer patients

Polymorphismes du CYP2D6 et tamoxifène : perspectives thérapeutiques dans la prise en charge des cancers du sein hormonodépendants

Decreased folylpolyglutamate synthetase activity in tumors resistant to fluorouracil-folinic acid treatment: clinical data

A clinically applicable assay for tumoral thymidylate synthase combining reverse transcriptase–PCR and High-performance liquid chromatography

Enzyme-Linked Immunosorbent Assay for Pharmacological Studies Targeting Hypoxia-Inducible Factor 1α

CYP2D6 polymorphisms and tamoxifen: therapeutic perspectives in the management of hormonodependent breast cancer patients

Tamoxifen metabolism: pharmacokinetic and in vitro study

Comparison between short or long exposure to 5-fluorouracil in human gastric and colon cancer cell lines: biochemical mechanism of resistance

Synergistic efficacy of 3n-butyrate and 5-fluorouracil in human colorectal cancer xenografts via modulation of DNA synthesis

Suchergebnisse filtern